A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

Clinical trial NCT06541847 · RECRUITING

Trial details

NCT number: NCT06541847
Sponsor: Healx Limited
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis Type 1

Start date: 2025-02-10
Primary completion: 2027-06-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.